Patients on warfarin who had a chance of winning money when they took their medicine daily as prescribed showed higher adherence rates than patients who were not offered incentives, a University of Pennsylvania study found. Researchers said the money was less important than the daily engagement, which could point the way for insurers, prescribers and pharmacies to develop adherence programs. The New England Healthcare Institute estimates that $290 billion, or 13% of total health care spending each year, is due to health-related expenditures, such as hospital visits, tied to prescription nonadherence.

Related Summaries